Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C Virus

OBJECTIVE: Patient-reported outcomes (PROs) are important measures of the quality of life (QOL) and symptoms in patients with hepatitis C virus (HCV). We evaluated the PROs at the beginning of direct-acting antiviral (DAA) treatment and three years later. A low QOL in patients with chronic liver dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichikawa, Tatsuki, Miyaaki, Hisamitsu, Miuma, Satoshi, Motoyoshi, Yasuhide, Yamashima, Mio, Yamamichi, Shinobu, Koike, Makiko, Nakano, Yusuke, Honda, Tetsurou, Yajima, Hiroyuki, Uehara, Ryouhei, Miyazaki, Osamu, Kuribayashi, Yasutaka, Kira, Keiji, Taura, Naota, Nakao, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691030/
https://www.ncbi.nlm.nih.gov/pubmed/33132304
http://dx.doi.org/10.2169/internalmedicine.5102-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691030/
https://www.ncbi.nlm.nih.gov/pubmed/33132304
http://dx.doi.org/10.2169/internalmedicine.5102-20

Ejemplares similares